VARCERB Trademark
Trademark Overview
On Tuesday, August 5, 2003, a trademark application was filed for VARCERB with the United States Patent and Trademark Office. The USPTO has given the VARCERB trademark a serial number of 78283116. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 13, 2011. This trademark is owned by Glaxo Group Limited. The VARCERB trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations; Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations
General Information
| Serial Number | 78283116 |
| Word Mark | VARCERB |
| Filing Date | Tuesday, August 5, 2003 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, May 13, 2011 |
| Registration Number | 2893378 |
| Registration Date | Tuesday, October 12, 2004 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 20, 2004 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations; Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, May 13, 2011 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Middlesex UB6 0NN
GB |
| Party Name | Glaxo Group Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Middlesex UB6 0NN
GB |
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Middlesex UB6 0NN
GB |
Trademark Events
| Event Date | Event Description |
| Friday, May 13, 2011 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, October 12, 2004 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 20, 2004 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 30, 2004 | NOTICE OF PUBLICATION |
| Saturday, April 24, 2004 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 4, 2004 | Sec. 1(B) CLAIM DELETED |
| Wednesday, February 4, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 4, 2004 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 26, 2004 | NON-FINAL ACTION E-MAILED |
| Monday, January 26, 2004 | ASSIGNED TO EXAMINER |
